ACI Files Comments with the FTC Regarding PBM Business Practices and their Impact on Drug Prices

The Federal Trade Commission is currently collecting public comments on the “Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers.” Today ACI filed its comments with the FTC. The comments are available here.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin